Operational readiness and infrastructure supporting industry-sponsored clinical trials.
At a Glance
- 2,300 sq. ft. dedicated research facility
- 4 Principal Investigators + 4 Sub-Investigators (formal back-up coverage)
- 6 dedicated research staff + 2 dedicated recruiters
- ~8,000-patient internal database + affiliated referral network
- Early-phase readiness: PK/PD + IV infusion + close monitoring
- FDA-inspected site with NAI outcomes (SOP-driven operations)
Investigators & Research Staff
Built to support multiple concurrent studies with consistent oversight and continuity.
- PI and Sub-I coverage model maintained
- In-house Sub-I specialties: Endocrinology, Nephrology, Infectious Diseases, Psychiatry
- Bilingual research staff (English / Spanish)
Patient Access & Recruitment
- EHR-supported pre-screening and internal database outreach
- Physician referrals and affiliated practices
- Digital outreach and community engagement
Facility & Clinical Capabilities
- 4 exam rooms + 10 inpatient beds
- Dedicated PK / IV infusion area
- Pharmacy capabilities (blinded/unblinded storage)
- On-site lab and sample handling workflows
Early-Phase, Hybrid & Start-Up Readiness
- Phase I + PK/PD study experience
- Patient overnight monitoring capabilities
- Hybrid/remote trial support
- Contract execution typically under two weeks
- Central IRB capable
Laboratory & Sample Handling
- Two on-site laboratories
- −20°C and −80°C freezers
- Centrifuges (ambient & refrigerated)
- CLIA-waived certification
- Secure processing workflows
Equipment & Infrastructure
- IV pumps and infusion equipment
- Crash cart and emergency equipment
- Manual and digital blood pressure systems
- Digital, beam, and BIA scales
- Spirometry and FeNO
- Oximeters and nebulizers
- Hand dynamometer
- Ophthalmoscope and otoscope
Quality & Regulatory Standards
FDA-inspected site with No Action Indicated (NAI) outcomes
SOP-driven operations
GCP- and HIPAA-trained research staff
Partnership Opportunities
We collaborate with sponsors and CROs on early- and late-phase trials, PK/PD, infusion studies, and long-term research partnerships.
